SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-286117
Filing Date
2020-11-05
Accepted
2020-11-05 06:06:17
Documents
49
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d86765d10q.htm   iXBRL 10-Q 848793
2 EX-31.1 d86765dex311.htm EX-31.1 10597
3 EX-31.2 d86765dex312.htm EX-31.2 10789
4 EX-32.1 d86765dex321.htm EX-32.1 5902
  Complete submission text file 0001193125-20-286117.txt   3412955

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20200930.xsd EX-101.SCH 24478
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20200930_cal.xml EX-101.CAL 24357
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20200930_def.xml EX-101.DEF 82145
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20200930_lab.xml EX-101.LAB 226160
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20200930_pre.xml EX-101.PRE 168779
10 EXTRACTED XBRL INSTANCE DOCUMENT d86765d10q_htm.xml XML 520937
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 201288475
SIC: 2834 Pharmaceutical Preparations